Dr. Frank Hensel
Principal at HTGF
About
Dr. Frank Hensel is a scientist-founder of OncoMab and Principal with hands-on startup experience, specializing in tumor-reactive and human monoclonal antibody therapies and leading early-stage drug development.
Invests in
BiotechClimate TechDeep TechHardwareMedical DevicesSaaS